Fragrant Prosperity Holdings Ltd Appointment of Director (7338T)
March 29 2021 - 01:00AM
UK Regulatory
TIDMFPP
RNS Number : 7338T
Fragrant Prosperity Holdings Ltd
29 March 2021
29 March 2021
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR
INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA,
CANADA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR
JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE
OR DISTRIBUTION WOULD BE UNLAWFUL.
Fragrant Prosperity Holdings Limited
("FPP" or the "Company")
Appointment of Director
The Board of Directors of Fragrant Prosperity Holdings Limited,
which is seeking an acquisition in several sectors but is currently
focused on Cannabis Therapeutics, is pleased to announce the
appointment of Dr. Daniel S. Reshef, MD, MPH, PhD to the Board of
Directors as a non-executive director. This appointment will become
effective as of March 31, 2021.
Dr. Daniel Reshef is a dual Israeli and USA Citizen, currently
living in the USA, with strong ties to Israel, Israel medical
research centres and a vast array of relationships in the global
pharmaceutical sector.
Dr Reshef's extensive career with over twenty five years in drug
development encompasses many facets of the Pharmaceutical sector,
gained through senior management positions at leading companies
such as Hoffman La Roche, Genentech, Bristol Myers Squibb, and in
his current capacity as the Therapeutic Area Global Head for a
major global Pharmaceutical Company. His scientific experience
includes skills in regulatory, medical affairs, drug safety
operations and clinical trials epidemiology with leadership
experience in early drug development from phase 1 to phase IV, and
in multiple therapeutic areas.
Dr. Reshef is a board-certified physician, graduate of the
Hebrew University and Hadassah Medical School in Jerusalem, and has
earned his MPH and PhD in Epidemiology from Johns Hopkins
University.
Craig Marshak Chairman of Fragrant Prosperity commented: "I have
personally known and worked with Dr. Daniel Reshef for well over 7
years, and have always been impressed with his world wide
experience and skill set. I am delighted to welcome him to the
Board and look forward to the additional expertise that he brings
to the Company"
Current and previous Directorships within the last 5 years that
Dr Reshef holds are set out below:
Current Previous 5 years
ABTI - Alterola pharmaceuticals
- Director
-----------------
QEBR - Virtual Medical - Director,
Vice Chair
-----------------
Israel Venture Partners - Director
-----------------
*Ends*
For more information:
http://www.fragrantprosperityholdings.com/
Fragrant Prosperity Holdings
Limited
Simon Retter/Craig Marshak +44 (0) 20 3137 1902
Broker: Optiva Securities
Vishal Balasingham +44 (0) 20 3137 1903
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOADKCBKBBKKKNB
(END) Dow Jones Newswires
March 29, 2021 02:00 ET (06:00 GMT)
Fragrant Prosperity (LSE:FPP)
Historical Stock Chart
From Feb 2024 to Mar 2024
Fragrant Prosperity (LSE:FPP)
Historical Stock Chart
From Mar 2023 to Mar 2024